Example: Heart Attack

Search clinical trials for: Asparaginase

Total 258 results

NCT00819351

Completed

ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia Intermittent Versus Continuous PEG Asparaginase

Conditions: Acute Lymphoblastic Leukemia
NCT02647190

Withdrawn

Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older

Conditions: Acute Lymphoblastic Leukemia (ALL); Newly Diagnosed Philadelphia Chromosome Negative; Aged 60 Years or Older
NCT04414969

Recruiting

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Conditions: Immune Checkpoint Inhibitor; Chemotherapy Effect; Epigenetic Disorder; NK/T-cell Lymphoma of Nasal Cavity
NCT01910428

Terminated

L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL

Conditions: Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma
NCT00506597

Completed

Erwinase Study in Patients With Acute Lymphoblastic Leukemia

Conditions: Leukemia
NCT01518517

Completed

GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia

Conditions: Acute Lymphoblastic Leukemia, in Relapse
NCT00854425

Completed

L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma

Conditions: Lymphoma
NCT03668392

Recruiting

Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Conditions: Acute Lymphoblastic Leukemia
NCT02197650

No longer available

Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase

Conditions: Acute Lymphoblastic Leukemia
NCT02283190

Completed

1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)

Conditions: Acute Myeloid Leukemia
NCT02150928

Withdrawn

An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)

Conditions: Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
NCT00590915

No longer available

Erwinase Master Treatment Protocol

Conditions: Leukemia, Acute Lymphoblastic; Acute Lymphoid Leukemia
NCT00983138

Completed

Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)

Conditions: Acute Lymphoid Leukemia
NCT04364451

Recruiting

Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase.

Conditions: Acute Lymphoblastic Leukemia
NCT00784017

Completed

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

Conditions: Acute Lymphoblastic Leukemia
NCT04187248

Completed

The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008

Conditions: Acute Lymphoblastic Leukemia
NCT01643408

Completed

A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy

Conditions: Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma
NCT00184041

Completed

Intensified Post Remission Therapy Containing PEG-Asparaginase

Conditions: Acute Lymphoblastic Leukemia
NCT00957320

Withdrawn

Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL)

Conditions: Acute Lymphoblastic Leukemia
NCT00192673

Unknown status

Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses

Conditions: Acute Lymphoblastic Leukemia
NCT00537030

Completed

Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia

Conditions: Adult Acute Lymphoblastic Leukemia; Childhood Acute Lymphoblastic Leukemia
NCT01878708

Terminated

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Conditions: T-Cell Lymphoma; Relapsed T-Cell Lymphoma; Refractory T-Cell Lymphoma
NCT03156790

Recruiting

PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia

Conditions: Acute B-Cell Lymphoblastic Leukaemia
NCT00933673

Unknown status

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

Conditions: Lymphoma
NCT02718755

Withdrawn

Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

Conditions: Hematologic Malignancy